| ALB | Albumin |
| ALD | Alcoholic liver disease |
| ALF | Alcoholic liver fibrosis |
| ALT | Alanine aminotransferase |
| ALP | Alkaline phosphatase |
| AST | Aspartate aminotransferase |
| α-SMA | alpha-Smooth muscle acti |
| BA | Bile acid |
| Bax | Bcl-2-associated x protein |
| BCL-2 | B-cell lymphoma 2 |
| BDL | Bile duct ligation |
| CCl4 | Carbon tetrachloride |
| Col | Collagen type |
| CTP | Child-Turcotte-Pugh |
| EtOH | Ethyl alcohol |
| GGT | gamma Glutamyl peptidase |
| GSH | Glutathione |
| HCC | Hepatocellular carcinoma |
| HE | Hepatic encephalopathy |
| HSP | Heat shock proteins |
| IL | Interleukin |
| iNOS | Inducible nitric oxide synthase |
| MAPK | Mitogen-activated protein kinase |
| MDA | Malondialdehyde |
| MHE | Minimal hepatic encephalopathy |
| MELD | Model for end-stage liver disease |
| Mmp | Matrix metallopeptidases |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated b cells |
| SIRT | Selective internal radiation therapy |
| SCFAs | Short chain fatty acids |
| SOD | Superoxide dismutase |
| TAA | Thioacetamide |
| TEER | Transepithelial electrical resistance |
| TG | Triglycerides |
| TBIL | Total bilirubin |
| Timp | Tissue inhibitor of metallopeptidase |
| TLR | Toll-like receptor |
| TNF-α | Tumor necrosis factor alpha |
| Zo-1 | Zonula occludenes-1 |